Clene Inc. Warrant

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch CLNNW and buy or sell other stocks, ETFs, and their options commission-free!

About CLNNW

Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. 

CEO
Robert Dee Etherington, MBA
CEORobert Dee Etherington, MBA
Employees
Employees
Headquarters
Salt Lake City, Utah
HeadquartersSalt Lake City, Utah
Founded
2013
Founded2013
Employees
Employees

CLNNW Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
16.26K
Average volume16.26K
High today
$0.033
High today$0.033
Low today
$0.022
Low today$0.022
Open price
$0.032
Open price$0.032
Volume
64.20K
Volume64.20K
52 Week high
$0.079
52 Week high$0.079
52 Week low
$0.022
52 Week low$0.022
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.